A127209-100MG
A127209-10MG
A127209-25MG
A127209-50MG
A127209-5MG
ALA127209100MGEA
235.51
USD
InStock
ALA127209100MG
ALA127209-10MG
ALA127209-25MG
ALA127209-50MG
ALA127209-5MG
AZD-4547 ≥99%, Moligand™
AZD-4547
AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3 with IC50 of 0.2 nM/2.5 nM/1.8 nM, weaker activity against FGFR4, VEGFR2(KDR), and little activity observed against IGFR, CDK2, and p38. Phase 2/3.A novel selective FGFR inhibitor targeting FGFR1, FGFR2, and FGFR3.